A clinical study report is a comprehensive document that describes the objectives, design, methodology, statistical analysis, efficacy results, and safety findings of a completed clinical trial. It is included in the clinical efficacy and safety module of regulatory submission dossiers and serves as the primary source reviewers use to evaluate the benefit-risk profile of an investigational product and to support labeling claims.
In translation and localization, clinical study reports are often translated as part of eCTD Module 5 or similar clinical submission packages for marketing applications. Translators handle large data tables, adverse event narratives, statistical output, and figure legends, and must keep terminology aligned with the protocol, statistical analysis plan, and case report forms.
A frequent mistake is translating adverse event narratives with added interpretation or omitting causal language such as “possibly related,” which alters safety assessment. Statistical terms may also drift from those used in the protocol, for example rendering “treatment arm” differently across sections, making efficacy results harder for reviewers to verify.
FDA, CE/MDR and NMPA reviewers assess the submitted wording itself. Regulatory bodies require traceable, accountable translation, and an inconsistent term can delay or fail a submission.
Angel Translation locks terms like this into a project terminology base before expert review begins, so the same source term resolves to the same target term across every document in a submission — and stays consistent in the next revision. See the 8-step AI + expert workflow.
Send us the files. Acknowledged in 4 hours, quoted in 24.
Request a Quote →Life Science solutions →